Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

32.7K
Overview
32.7K
What is Genetic Engineering?00:49

What is Genetic Engineering?

80.7K
Overview
80.7K
Cross-reactivity00:42

Cross-reactivity

33.4K
Overview
33.4K
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

64
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
64
Allergic Drug Reactions01:27

Allergic Drug Reactions

1.5K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.5K
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

86
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
86

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of new allergens in <i>Periplaneta americana</i> by omics and immunological techniques for cockroach-related allergic diseases: abridged secondary publication.

Hong Kong medical journal = Xianggang yi xue za zhi·2025
Same author

Timing of solid food introduction in Hong Kong children: abridged secondary publication.

Hong Kong medical journal = Xianggang yi xue za zhi·2024
Same author

Secondary use of dried blood spots from newborn screening.

Hong Kong medical journal = Xianggang yi xue za zhi·2024
Same author

Skin microbial signatures for eczema: a birth cohort study (abridged secondary publication).

Hong Kong medical journal = Xianggang yi xue za zhi·2024
Same author

The associations of pre-pregnancy BMI and gestational weight gain with maternal gut microbiota.

Beneficial microbes·2024
Same author

Indications for house dust mite allergen-specific immunotherapy.

Hong Kong medical journal = Xianggang yi xue za zhi·2023

Related Experiment Video

Updated: Mar 3, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.8K

Genetically modified foods and allergy.

T H Lee1, H K Ho2, T F Leung3

  • 1Allergy Centre, Hong Kong Sanatorium and Hospital, Happy Valley, Hong Kong.

Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi
|May 6, 2017
PubMed
Summary
This summary is machine-generated.

Genetically modified foods offer solutions but face public anxiety due to unproven safety concerns. Open dialogue and transparent labeling are crucial for public trust in biotech crops.

Keywords:
AllergensPlants, genetically modifiedSoybeans

More Related Videos

Zebrafish Animal Model for the Study of Allergic Reactions in Response to Tick Saliva Biomolecules
07:01

Zebrafish Animal Model for the Study of Allergic Reactions in Response to Tick Saliva Biomolecules

Published on: September 16, 2022

2.2K
Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

12.9K

Related Experiment Videos

Last Updated: Mar 3, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.8K
Zebrafish Animal Model for the Study of Allergic Reactions in Response to Tick Saliva Biomolecules
07:01

Zebrafish Animal Model for the Study of Allergic Reactions in Response to Tick Saliva Biomolecules

Published on: September 16, 2022

2.2K
Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

12.9K

Area of Science:

  • Agricultural Science
  • Food Science
  • Biotechnology

Background:

  • Genetically modified (GM) crops have been commercially available for 25 years, with global cultivation covering two billion hectares.
  • GM soybean protein is widely used in processed foods, and GM foods are consumed globally.
  • GM food technology presents potential solutions for food and medicine challenges.

Purpose of the Study:

  • To address public anxiety surrounding the safety of genetically modified foods.
  • To advocate for evidence-based dialogue between scientists and the public.
  • To propose strategies for enhancing the safety assessment and transparency of GM foods.

Main Methods:

  • Review of current concerns regarding GM food safety, including allergenicity and toxicity.
  • Analysis of existing pre-marketing testing protocols for GM foods.
  • Discussion of public perception and communication strategies related to GM food technology.

Main Results:

  • Despite rigorous testing, public anxiety persists, sometimes fueled by unsubstantiated criticisms.
  • Concerns about allergenicity and toxicity are major drivers of public apprehension.
  • Some countries have rejected GM food aid due to perceived health risks.

Conclusions:

  • Scientists must engage the public in evidence-based dialogue to alleviate concerns about GM foods.
  • Improved and validated safety testing methods for new foods are necessary.
  • Post-launch monitoring, mandatory ingredient labeling, and transparent information are essential for public trust and traceability.